Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × osimertinib × Endocrine × Clear all

Sponsor

Cancer Type

Thoracic 7 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Dermatologic 1 CNS 1 Breast 1

Interventions

selpercatinib 2 lutetium Lu 177 dotatate 2 entrectinib 2 cabozantinib 2 Fulvestrant 2 trametinib 1 ribociclib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 dabrafenib 1 copper dotatate CU-64 1 belzutifan 1 X-Rays 1 Specimen Handling 1 Phantoms, Imaging 1 Octreotide 1 Magnetic Resonance Spectroscopy 1 Lutetium-177 1 Lutetium 1 Alpelisib 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡